Stratos Wealth Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,080
| Closed | -$750K | – | 1260 |
|
|
2021
Q2 | $750K | Sell |
4,080
-49
| -1% | -$9.01K | 0.02% | 637 |
|
|
2021
Q1 | $631K | Sell |
4,129
-304
| -7% | -$46.5K | 0.02% | 638 |
|
|
2020
Q4 | $693K | Sell |
4,433
-438
| -9% | -$68.5K | 0.02% | 562 |
|
|
2020
Q3 | $557K | Buy |
4,871
+288
| +6% | +$32.9K | 0.02% | 589 |
|
|
2020
Q2 | $514K | Buy |
4,583
+1,235
| +37% | +$139K | 0.02% | 583 |
|
|
2020
Q1 | $301K | Buy |
3,348
+1,158
| +53% | +$104K | 0.01% | 692 |
|
|
2019
Q4 | $237K | Buy |
+2,190
| New | +$237K | 0.01% | 849 |
|
|
2018
Q2 | – | Sell |
-1,655
| Closed | -$184K | – | 2868 |
|
|
2018
Q1 | $184K | Buy |
1,655
+307
| +23% | +$34.1K | 0.01% | 938 |
|
|
2017
Q4 | $161K | Sell |
1,348
-1,609
| -54% | -$192K | 0.01% | 967 |
|
|
2017
Q3 | $415K | Buy |
+2,957
| New | +$415K | 0.02% | 562 |
|